. 2022 Oct 13;46(1):75–83. doi: 10.1038/s41440-022-01046-4

Table 2.

The association of mean hourly systolic blood pressure between 1 and 24 h with outcomes

Outcome	N (%)	Crude			Adjusted. Model 1			Adjusted. Model 2
Outcome	N (%)	Odds ratio^a	95% CI^a	P	Odds ratio^a	95% CI^a	P	Odds ratio^a	95% CI^a	P
Death or disability	176/495 (35.6%)	1.17	1.00–1.37	0.0507	1.28	1.07–1.52	0.0051	1.25	1.03–1.52	0.0224
Adding 2 patients without available data^b	178/497 (35.8%)	1.17	1.00–1.36	0.0538	1.28	1.08–1.52	0.0050	1.25	1.03–1.52	0.0221
Hematoma expansion	76/486 (15.6%)	1.51	1.22–1.86	0.0001	1.45	1.16–1.81	0.0011	1.49	1.18–1.87	0.0005
Adding 13 patients with emergent surgery^c	89/499 (17.8%)	1.44	1.18–1.75	0.0003	1.38	1.13–1.68	0.0015	1.40	1.14–1.73	0.0014
Serious adverse events	88/499 (17.6%)	1.07	0.88–1.30	0.5114	1.11	0.90–1.36	0.3418	1.08	0.87–1.34	0.4892
Cardio-renal serious adverse events	7/499 (1.4%)	1.02	0.54–1.92	0.9478		—			—

Multivariable analysis is not done for cardio-renal serious adverse events because of a small event number

Model 1: adjusted for sex, age, and study group

Model 2: adjusted for sex, age, study group, baseline systolic blood pressure, baseline National Institutes of Health Stroke Scale score, baseline hematoma volume, lobar hematoma, and onset-to-randomization time

^aper 10 mmHg

^b2 patients added are regarded as having death or disability

^c13 patients added are regarded as having hematoma expansion